Abstract
5-Aminolevulinic acid (ALA) or its derivative methyl 5-aminolevulinate (MAL) combined with folic acid was applied in nude mice bearing human colon adenocarcinoma. The aim of the study is to see whether folic acid may increase biosynthesis of porphyrins in tumor tissue after systemic or topical administration of ALA or MAL. The production of porphyrins was determined by spectrofluorometric measurements with an optical fibre probe. It was found that the porphyrin production after i.p injection of 200 mg kg−1 ALA or MAL was significantly increased by i.p injection of 100 mg kg−1 folic acid. However, in the case of topically applied 20% ALA, folic acid had no effect. In the case of topically applied 20% MAL, folic acid (i.p or topically applied) reduced the porphyrin synthesis. This might be used for the protection of normal skin against photosensitization. The effects of folic acid were similar in tumors and normal skin. Two mechanisms may explain the results: enhancement of the efficiency of the rate-limiting enzyme porphobilinogen deaminase by folic acid or interference of folic acid with the transport of ALA and MAL to and into the cells synthesizing porphyrins in the tissues. The present data seem to favour the latter mechanism. Folic acid may have a role as an adjuvant in photodynamic therapy with systemically administered ALA and its derivatives.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. R. Moore, K. E. McColl, C. Rimington and S. A. Goldbert, in Disorders of porphyrin metabolism, ed. M. M. Wintrobe, Plenum Press, New York, 1987, pp. 73–116.
N. Gordon, The acute porphyries, Brain Dev., 1999, 21, 373–377.
F. J. DiMario Jr., J. J. Quinn, E. L. Zalneraitis, D. A. Whiteman and B. S. Russman, Folate deficiency and acute intermittent porphyria in a 12-year-old boy, Neurology, 1993, 43, 1438–1439.
E. A. Wider de Xifra, A. M. Batlle, A. M. Stella, S. Malamud, Acute intermittent porphyria - another approach to therapy, Int. J. Biochem., 1980, 12, 819–822.
M. L. Kotler, A. A. Juknat, S. R. CorreaGarcia, F. Princ and A. M. Batlle, In vitro sulfamerazine inhibition of rat blood uroporphyrinogen I synthetase and its reversal by folic acid, Med. Sci. Res., 1988, 16, 983–984.
M. Kohashi, R. P. Clement, J. Tse and W. N. Piper, Rat hepatic uroporphyrinogen III co-synthase. Purification and evidence for a bound folate coenzyme participating in the biosynthesis of uroporphyrinogen III, Biochem. J., 1984, 220, 755–765.
G. O. Noriega, A. A. Juknat and A. M. Batlle, Non-essential activation of rat liver porphobilinogen-deaminase by folic acid, Z. Naturforsch., C, 1992, 47, 416–419.
S. Sassa and A. Kappas, Genetic, metabolic, and biochemical aspects of the porphyrias, Adv. Human Genet., 1981, 11, 121–231.
M. M. Qualls and Thompson D. H. Chloroaluminum, phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity, Int. J. Cancer, 2001, 93, 384–392.
R. Schneider, F. Schmitt, C. Frochot, Y. Fort, N. Lourette, F. Guillemin, J. F. Muller and M. Barberi-Heyob, Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy, Bioorg. Med. Chem., 2005, 13, 2799–2808.
S. D. Weitman, R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. J. Zurawskir and B. A. Kamen, Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Cancer Res., 1992, 52, 3396–3401.
R. H. Jindra, A. Kubin, H. Kolbabek and G. Alth, W. Dobrowsky, Ambulant photodynamic therapy of superficial malignomas with 5-ALA in combination with folic acid and use of noncoherent light, Drugs Exp. Clin. Res., 1999, 25, 37–41.
Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K. E. Giercksky and J. M. Nesland, 5-Aminolevulinic acid–based photodynamic therapy. Clinical research and future challenges, Cancer, 1997, 79, 2282–2308.
P. Babilas, S. Karrer, A. Sidoroff, M. Landthaler and R. M. Szeimies, Photodynamic therapy in dermatology - an update, Photodermatol. Photoimmunol. Photomed., 2005, 21, 142–149.
J. Moan, L. W. Ma, A. Juzeniene, Q. Peng and V. Iani, Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters, Int. J. Cancer, 2003, 103, 132–135.
L. W. Ma, J. Moan, Q. Peng and V. Iani, Production of protoporphyrin IX induced by 5 aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound, Int. J. Cancer, 1998, 78, 464–469.
Q. Peng, T. Warloe, J. Moan, H. Heyerdahl, J. M. Nesland and K. E. Giercksky, Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma, Photochem. Photobiol., 1995, 62, 906–913.
A. Bugaj, V. Ian, A. Juzeniene, P. Juzenas, L. W. Ma and J. Moan, The effect of dimethyl sulfoxide, 1-[2-(decylthio-)ethyl-]azacyclopentane-2-one and labrafac on porphyrin formation in mouse skin during topical application of methyl 5-aminolevulinate; a fluorescence and extraction study, Photodiagn. Photodyn. Ther., 2006, 3, 27–33.
O. A. Gederaas, A. Holroyd, S. B. Brown, D. Vernon, J. Moan and K. Berg, 5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line, Photochem. Photobiol., 2001, 73, 164–169.
E. Rud, O. Gederaas, A. Hogset and K. Berg, 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters, Photochem. Photobiol., 2000, 71, 640–647.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, L., Steindal, A.E., Juzeniene, A. et al. The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate. Photochem Photobiol Sci 5, 755–759 (2006). https://doi.org/10.1039/b603828j
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b603828j